Hashimoto's Symptoms, Diagnosis, and Treatment: What Most Patients Are Never Told

Hashimoto's thyroiditis is the most common cause of hypothyroidism in the United States. It is also frequently missed in its earlier stages.

Not because it is rare or obscure. Because the way thyroid disease is typically screened for often does not capture what is happening early in the autoimmune process.

Here is what you need to know.

What causes Hashimoto's

Hashimoto's is an autoimmune condition. The immune system loses tolerance to the thyroid gland and mounts an attack against it, producing antibodies, most commonly thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TGAb), that drive chronic inflammation and progressive destruction of thyroid tissue over time.

The exact trigger is not fully understood, but research points to a combination of genetic predisposition and environmental factors. A family history of autoimmune disease significantly raises risk. Hashimoto's is far more common in women than in men and most commonly presents between the ages of 30 and 50, though it can develop at any age.

Environmental contributors may include iodine excess or deficiency, smoking, chronic stress, certain infections, and environmental exposures. Emerging research has also implicated gut microbiome dysbiosis as a potential contributor. The gut plays a major role in immune regulation, and disruptions in the microbiome may influence both the onset and progression of autoimmune thyroid disease.

Why Hashimoto's gets missed

Standard thyroid screening often relies primarily on TSH. This is where the gap begins.

Early in Hashimoto's, TSH may remain completely normal. The antibody-driven inflammatory process has already begun, the immune attack is underway, and the patient may be experiencing significant Hashimoto's symptoms, but TSH has not yet shifted enough to flag. A provider ordering only TSH may see a normal result and conclude the thyroid is functioning appropriately.

This can go on for years.

Hashimoto's symptoms are also notoriously nonspecific:

These symptoms overlap substantially with other conditions including iron deficiency, perimenopause, depression, chronic stress, sleep deprivation, and other autoimmune disorders. Patients are frequently treated for those conditions while the underlying autoimmune process is never identified.

Hashimoto's can also fluctuate in ways that further complicate diagnosis. In earlier phases, intermittent thyroid cell destruction may release stored thyroid hormone into the bloodstream, producing transient hyperthyroid symptoms such as anxiety, palpitations, insomnia, or weight loss, sometimes called a Hashimoto's flare, before the more typical hypothyroid phase develops.

A more comprehensive thyroid evaluation includes TSH, Free T4, thyroid antibodies including TPOAb and TGAb, and when clinically appropriate, Free T3 and thyroid ultrasound. TPO antibodies are present in over 90% of Hashimoto's cases. Thyroid ultrasound may reveal characteristic inflammatory changes even before significant abnormalities appear on standard thyroid labs.

Neither thyroid antibodies nor ultrasound are typically included in a standard annual physical.

What to consider when managing Hashimoto's

The conventional approach to Hashimoto's is to monitor TSH and begin levothyroxine once thyroid hormone levels decline enough to meet criteria for hypothyroidism. That approach is appropriate and evidence-based.

But it leaves a gap.

A substantial number of patients who are biochemically euthyroid on levothyroxine, meaning their TSH is technically in range, continue to experience fatigue, cognitive symptoms, hair loss, weight changes, or low mood. If you have a normal TSH but still feel symptomatic, you are not imagining it. This is documented in the literature and likely reflects multiple overlapping factors: persistent autoimmune activity, nutritional deficiencies, impaired T4-to-T3 conversion, and other comorbid conditions that coexist with thyroid disease.

Several areas deserve clinical attention beyond TSH alone.

Selenium for Hashimoto's

Selenium is one of the better-studied nutritional interventions in Hashimoto's disease. A 2024 systematic review and meta-analysis of randomized clinical trials found that selenium supplementation significantly reduced TPO antibody levels and TSH independent of baseline selenium status and independent of whether the patient was on thyroid hormone replacement. The evidence is clinically meaningful enough to warrant consideration in appropriate patients.

Iron deficiency

Iron deficiency impairs thyroid hormone synthesis and T4-to-T3 conversion. Ferritin should be evaluated in patients with persistent Hashimoto's symptoms, particularly menstruating women, because iron deficiency without anemia is extremely common and symptomatically overlaps almost entirely with hypothyroidism.

Vitamin D

Vitamin D deficiency is consistently more prevalent in autoimmune thyroid disease than in the general population. Repletion is low risk and appropriate when deficiency is identified.

T4-to-T3 conversion

Levothyroxine provides T4 only. Peripheral conversion into active T3 depends on multiple physiologic factors including selenium, zinc, iron status, caloric intake, inflammation, and overall metabolic health. In some patients, a normal TSH may not fully reflect optimal peripheral thyroid hormone availability. Free T3 may be clinically useful in selected symptomatic patients who remain unwell on levothyroxine despite a normal TSH.

Gut health and absorption

The relationship between the gut microbiome and autoimmune thyroid disease is an active area of research. Gut dysbiosis may influence immune regulation, intestinal permeability, inflammation, and nutrient absorption. Gastrointestinal conditions such as SIBO, celiac disease, and chronic gastritis may also impair levothyroxine absorption and contribute to persistent symptoms or higher dose requirements.

Hashimoto's and diet

Hashimoto's diet recommendations are frequently overstated. In patients with celiac disease or clear non-celiac gluten sensitivity, removing gluten is appropriate and may reduce autoimmune activity. In patients without either condition, current evidence does not support a universal gluten-free recommendation. That said, an overall anti-inflammatory dietary pattern emphasizing micronutrient density, fiber, omega-3 fatty acids, and minimally processed foods is broadly supportive of metabolic and immune health.

The bigger picture

Managing Hashimoto's well means asking not only whether the TSH is in range, but why a patient still feels unwell when it is. If you have been told your thyroid labs are normal but continue to experience fatigue, brain fog, hair loss, or weight changes, Hashimoto's thyroiditis, and the factors that compound it, may not have been fully evaluated.

The autoimmune process driving the disease does not necessarily stop when TSH normalizes. And the downstream effects, on energy, cognition, mood, metabolism, menstrual health, and overall quality of life, deserve more attention than a single lab value alone.

Also in this series: Hashimoto's Diet: What the Evidence Actually Supports